Leukotrienes and Atherosclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|11|7|882-887

ISSN： 1389-4501

Source： Current Drug Targets, Vol.11, Iss.7, 2010-07, pp. : 882-887

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leukotrienes as Mediators of Asthma

By Nicosia S.   Capra V.   Rovati G.E.  

Pulmonary Pharmacology & Therapeutics, Vol. 14, Iss. 1, 2001-01 ,pp. : 3-19

Academic Press

Access to resources Recommend Favorite

Targeting Leukotrienes for the Treatment of COPD?

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 8, Iss. 4, 2009-09 ,pp. : 297-306

Bentham Science Publishers

Access to resources Recommend Favorite

Leukotrienes, Antileukotrienes and Asthma

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 7, 2008-06 ,pp. : 647-656

Bentham Science Publishers

Access to resources Recommend Favorite

Current treatment of asthma - focus on leukotrienes

By Crowther S.D.   Rees P.J.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 5, 2000-07 ,pp. : 1021-1040

Informa Healthcare

Access to resources Recommend Favorite

Leukotrienes and Antileukotriene Therapy in Allergic Rhinitis

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 7, Iss. 1, 2008-03 ,pp. : 16-20

Bentham Science Publishers

Access to resources Recommend Favorite